Method development for fecal lipidomics profiling - PubMed (original) (raw)
. 2013 Jan 15;85(2):1114-23.
doi: 10.1021/ac303011k. Epub 2012 Dec 26.
Affiliations
- PMID: 23210743
- PMCID: PMC3928122
- DOI: 10.1021/ac303011k
Method development for fecal lipidomics profiling
Katherine E Gregory et al. Anal Chem. 2013.
Abstract
Robust methodologies for the analysis of fecal material will facilitate the understanding of gut (patho)physiology and its role in health and disease and will help improve care for individual patients, especially high-risk populations, such as premature infants. Because lipidomics offers a biologically and analytically attractive approach, we developed a simple, sensitive, and quantitatively precise method for profiling intact lipids in fecal material. The method utilizes two separate, complementary extraction chemistries, dichloromethane (DCM) and a methyl tert-butyl ether/hexafluoroisopropanol (MTBE) mixture, alone or with high pressure cycling. Extracts were assessed by liquid chromatography-high-resolution mass spectrometry-based profiling with all ion higher energy collisional dissociation fragmentation in both positive and negative ionization modes. This approach provides both class-specific and lipid-specific fragments, enhancing lipid characterization. Solvents preferentially extracted lipids based on hydrophobicity. More polar species preferred MTBE; more hydrophobic compounds preferred DCM. Pressure cycling differentially increased the yield of some lipids. The platform enabled analysis of >500 intact lipophilic species with over 300 lipids spanning 6 LIPID MAPS categories identified in the fecal matter from premature infants. No previous report exists that provides these data; thus, this study represents a new paradigm for assessing nutritional health, inflammation, and infectious disease in vulnerable populations.
Figures
Figure 1. Experimental Design
The pooled fecal slurry was made by starting with well-mixed, pooled sample. 150 mg solid fecal sample per 3 ml water was combined and vortexed well to form a slurry. The slurry was diluted 1:3 and 1:10 in water. 180 µl of I.S. was added to 1020 µl of stock and each dilution. This yielded 2 mg, 0.6 mg, and 0.2 mg fecal material and 7.5 µl I.S. per 50 µl sample aliquot. Lipids were extracted using either a modified Bligh and Dyer method with DCM in place of CF, or an MTBE/HFIP mixture. The use of pressure at 35,000 psi for 30 cycles was applied to half of the samples, whereas the other half were vortexed extensively for approximately 10 minutes without the use of PCT.
Figure 2. Lipid Abundance and Precision Comparisons: Pressure vs No Pressure, Positive ion Mode
Each panel presents the following data:
- Top left set of panels: The linear scale of lipid abundance as defined by MS relative abundance. This panel emphasizes the most abundant lipids in the sample.
- Top right set of panels: The log scale of abundance as defined by MS relative abundance. This panel emphasizes the overall distribution of lipids in the sample. Within these panels, the lower left quadrant is populated by lipids whose overall signal has a relative abundance less than 1000 for either the X or Y condition. We expect that these lipids would be quantitatively unreliable for the LC-MS platform used. In contrast, lipids in the upper right would be expected to be quantitatively reliable, regardless of extraction approach. In contrast, lipids identified in the upper left or lower right panels would be expected to be much more analytically reliable under the "Y" or "X" extraction protocol, respectively.
- Bottom left set of panels: The overall CV scale of SIEVE data series. This panel shows 10,000 frames for positive ion mode and 7,000 frames for negative ion mode. These panels emphasize the total lipid yield based on the specific approach.
- Bottom right set of panels: The CV scale truncated at 40% CV. This panel emphasizes the "useful peaks" of lipids measured.
Figure 3. Lipid abundance and Precision Comparisons: Pressure vs No Pressure, Negative ion Mode
Details as in Figure 2
Figure 4. Lipid abundance and Precision Comparisons: DCM vs MTBE, Positive ion Mode
Details as in Figure 2
Figure 5. Schematic Showing Relationship between Fecal Lipid Extraction and Elution Characteristics
Panels A and B show two base peak chromatograms from the fecal lipid POOL sample, indicating the difference in signal based on ionization polarity and the need to study these samples in both modes, positive (A) and negative (B). Panel A shows 7 species and Panel B shows 5 species and their individual bar graphs representing their mean signal (±sem) across the 5 samples analyzed across all 3 dilutions for DCMP (DCM, pressure) and DCMS (DCM, no pressure), MTBEP (MTBE, pressure) and MTBES (MTBE, no pressure). The boxes around each graph represent the individual species’ extraction preference, and indicate the need for both extraction solvents and ionization modes to be used to achieve comprehensive lipidome analysis. Equivalent graphs of all 304 identified lipids are in the supplement.
Similar articles
- Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry.
Pizarro C, Arenzana-Rámila I, Pérez-del-Notario N, Pérez-Matute P, González-Sáiz JM. Pizarro C, et al. Anal Chem. 2013 Dec 17;85(24):12085-92. doi: 10.1021/ac403181c. Epub 2013 Nov 22. Anal Chem. 2013. PMID: 24266777 - Holistic Lipidomics of the Human Gut Phenotype Using Validated Ultra-High-Performance Liquid Chromatography Coupled to Hybrid Orbitrap Mass Spectrometry.
Van Meulebroek L, De Paepe E, Vercruysse V, Pomian B, Bos S, Lapauw B, Vanhaecke L. Van Meulebroek L, et al. Anal Chem. 2017 Nov 21;89(22):12502-12510. doi: 10.1021/acs.analchem.7b03606. Epub 2017 Oct 30. Anal Chem. 2017. PMID: 29053249 - Surface analysis of lipids by mass spectrometry: more than just imaging.
Ellis SR, Brown SH, In Het Panhuis M, Blanksby SJ, Mitchell TW. Ellis SR, et al. Prog Lipid Res. 2013 Oct;52(4):329-53. doi: 10.1016/j.plipres.2013.04.005. Epub 2013 Apr 24. Prog Lipid Res. 2013. PMID: 23623802 Review. - Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications.
Zhao YY, Wu SP, Liu S, Zhang Y, Lin RC. Zhao YY, et al. Chem Biol Interact. 2014 Sep 5;220:181-92. doi: 10.1016/j.cbi.2014.06.029. Epub 2014 Jul 9. Chem Biol Interact. 2014. PMID: 25014415 Review.
Cited by
- Global Fecal and Plasma Metabolic Dynamics Related to Helicobacter pylori Eradication.
Yap TW, Leow AH, Azmi AN, Callahan DL, Perez-Perez GI, Loke MF, Goh KL, Vadivelu J. Yap TW, et al. Front Microbiol. 2017 Mar 30;8:536. doi: 10.3389/fmicb.2017.00536. eCollection 2017. Front Microbiol. 2017. PMID: 28424674 Free PMC article. - Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them?
Tagliamonte S, Gill CIR, Pourshahidi LK, Slevin MM, Price RK, Ferracane R, Lawther R, O'Connor G, Vitaglione P. Tagliamonte S, et al. Eur J Nutr. 2021 Jun;60(4):2203-2215. doi: 10.1007/s00394-020-02398-8. Epub 2020 Oct 26. Eur J Nutr. 2021. PMID: 33104865 Free PMC article. - Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P, Mazzone G, Lembo V, D'Argenio G, Rossi A, Guido M, Savoia M, Salomone F, Mennella I, De Filippis F, Ercolini D, Caporaso N, Morisco F. Vitaglione P, et al. J Nutr Sci. 2019 Apr 22;8:e15. doi: 10.1017/jns.2019.10. eCollection 2019. J Nutr Sci. 2019. PMID: 31037218 Free PMC article. - A high-throughput platform for detailed lipidomic analysis of a range of mouse and human tissues.
Furse S, Fernandez-Twinn DS, Jenkins B, Meek CL, Williams HEL, Smith GCS, Charnock-Jones DS, Ozanne SE, Koulman A. Furse S, et al. Anal Bioanal Chem. 2020 May;412(12):2851-2862. doi: 10.1007/s00216-020-02511-0. Epub 2020 Mar 7. Anal Bioanal Chem. 2020. PMID: 32144454 Free PMC article. - A systemic workflow for profiling metabolome and lipidome in tissue.
Lu D, Xue L, Feng C, Jin Y, Wu C, Xie C, Gonzalez FJ, Wang G, Zhou Z. Lu D, et al. J Chromatogr A. 2019 Mar 29;1589:105-115. doi: 10.1016/j.chroma.2018.12.061. Epub 2018 Dec 30. J Chromatogr A. 2019. PMID: 30638710 Free PMC article.
References
- McGarr SE, Ridlon JM, Hylemon PB. J Clin Gastroenterol. 2005;39:98–109. - PubMed
- Zella GC, Israel EJ. Pediatr Rev. 2012;33:207–217. quiz 217–208. - PubMed
- Mathai J, Raju B, Bavdekar A. Indian Pediatr. 2011;48:37–42. - PubMed
- Hume G, Radford-Smith GL. Pathology. 2002;34:561–567. - PubMed
- Dharmani P, Chadee K. Curr Mol Pharmacol. 2008;1:195–212. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK040561/DK/NIDDK NIH HHS/United States
- U01 ES016048/ES/NIEHS NIH HHS/United States
- U01-ES16048/ES/NIEHS NIH HHS/United States
- K23 NR011320/NR/NINR NIH HHS/United States
- P30-DK040561/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources